- Business Wire•17 days ago
MELBOURNE, Australia--(BUSINESSWIRE)-- Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel ® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles ® ...
- Business Wire•4 months ago
MELBOURNE, Australia--(BUSINESSWIRE)-- Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced it has been granted Qualified Infectious Disease Product (QIDP) and Fast Track designation for VivaGel® BV by the US Food and Drug Administration (FDA). QIDP and Fast Track designations were granted independently for both the VivaGel® BV treatment and prevention indications for bacterial vaginosis (BV). This positive development recognises the high unmet medical need in the management of BV and the potential of VivaGel® BV to address that need for both treatment and prevention of recurrent BV, markets estimated to be worth in excess of US$1 billion globally.
- noodls•4 months ago
Starpharma receives $3.5M R&D tax incentive refund Melbourne, Australia; 22 December 2016: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced it has received the anticipated $3.5M of R&D ...
SPL.AX: Summary for STARPHARMA FPO - Yahoo Finance
Starpharma Holdings Limited (SPL.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
|Day's range||0.74 - 0.76|
|52-week range||0.59 - 0.88|
|PE ratio (TTM)||-11.75|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|